Personalized Medicine

简称 PERS MED ·ENGLAND ·出版周期 Quarterly ·年均收录 46 篇

1.8

最新影响因子

15.50%

自引率

较易

投稿难度

较慢,6-12周

审稿周期

期刊简介

Personalized Medicine是一本专注于个体化医疗领域的学术期刊，ISSN号为1741-0541，由英国出版商Future Medicine Ltd出版，出版地为英国，出版周期为双月刊。该杂志的影响因子根据年份有所不同，具体数值需查阅最新JCR报告，目前为非开放获取（非OA）期刊，被SCI收录，中科院分区情况需参考最新分区表。杂志的发文特点集中于个体化医疗的前沿研究，涵盖基因组学、生物标志物、药物开发、临床实践等方向，旨在推动精准医学的发展。其质量较高，文章经过同行评审，但需注意作为专业期刊，读者群体相对小众，可能存在投稿竞争激烈或审稿周期较长的风险。总体而言，该杂志是个体化医疗领域的重要学术平台。

影响因子趋势

近期发表

A cost-effective conventional endpoint PCR assay for HLA-B*13:01 genotyping to guide personalized dapsone therapy in leprosy in low-resource settings 2026-08-30

The historical evolution, technological transformation, and future vision of personalized medicine: a narrative review 2026-08-11

B‑cell activating factor gene polymorphisms rs9514828 and rs1041569 increase preeclampsia risk 2026-08-11

microRNA-27a-3p influences hepatocellular carcinoma cell migration and invasion via the TET1/p53 pathway 2026-09-04

Clinical implication of transcriptional dysregulation in the SHH-GLI pathway involving the GLI1 rs61739569 (T>C) variant toward chronic obstructive pulmonary disease (COPD) in North Indians 2026-08-10

Engineering innovations for precision medicine: sensors, AI biomarkers, and predictive interventions 2026-08-18

Molecular genetics analysis of genes BCL11A, HBS1L-MYB , and HBG2 variants association in thalassemic children 2026-09-08

Association of microRNA SNP variations and SNP-SNP interactions with breast cancer in Yemeni women 2026-08-28

CAUSAL artificial intelligence and data-driven decision intelligence in personalized medicine: a review of healthcare informatics systems 2026-08-14

In silico analysis of SH3BP2 genomic alterations and expression profiles in CRC 2026-09-02